Frequency Competitors

Delisted . USA . 
Stock . Frequency Therapeutics
FREQDelisted Stock  USD 0.52  0.03  5.45%   
Frequency Therapeutics competes with Lineage Cell, MAIA Biotechnology, Armata Pharmaceuticals, Portage Biotech, and Pmv Pharmaceuticals; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Frequency Therapeutics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Frequency Therapeutics to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Frequency Therapeutics competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Frequency Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.520.520.52
Details
Intrinsic
Valuation
LowRealHigh
0.440.440.57
Details
Naive
Forecast
LowNextHigh
0.600.600.60
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.480.540.61
Details

Frequency Therapeutics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Frequency Therapeutics and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Frequency and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Frequency Therapeutics does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
STTK
+ 0.77
PASG
PASG
+ 0.72
MAIA
OLMA
+ 0.66
LCTX
OLMA
+ 0.63
MAIA
PASG
+ 0.62
OLMA
STTK
+ 0.59
MAIA
  
High negative correlations   
STTK
- 0.87
SRRK
PASG
- 0.71
SRRK
STTK
- 0.5
PMVP
SRRK
- 0.5
MAIA
SRRK
- 0.35
OLMA
SRRK
- 0.33
LCTX

Risk-Adjusted Indicators

There is a big difference between Frequency Stock performing well and Frequency Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Frequency Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Frequency Therapeutics Competitive Analysis

The better you understand Frequency Therapeutics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Frequency Therapeutics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Frequency Therapeutics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
FREQ LCTX MAIA ARMP PRTG PMVP OLMA SRRK PASG STTK
 5.45 
 0.52 
Frequency
 16.67 
 0.50 
Lineage
 3.26 
 2.08 
MAIA
 7.14 
 2.25 
Armata
 2.21 
 4.62 
Portage
 2.55 
 1.61 
Pmv
 11.56 
 8.78 
Olema
 12.19 
 29.92 
Scholar
 5.56 
 0.51 
Passage
 0.99 
 1.00 
Shattuck
Market Volatility
(90 Days Market Risk)
Very steady
Dangerous
Unstable
Risky
Dangerous
Slightly risky
Somewhat reliable
Very risky
Dangerous
Very risky
Market Performance
(90 Days Performance)
Very Weak
Very Weak
Very Weak
Very Weak
Weak
Weak
Very Weak
OK
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Low
Very High
High
Very High
Average
Average
Low
Very High
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Strong Buy
Buy
Hold
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Sell
Sell
Strong Sell
Strong Sell
Cautious Hold
Current Ratio
6.77
3.01
2.78
5.59
11.73
24.76
19.75
9.69
9.23
9.46
Net Asset
121.24 M
101.02 M
7.57 M
98.36 M
7.78 M
252.15 M
276.94 M
311.04 M
150.54 M
159.56 M
EBITDA
(80.62 M)
(24.73 M)
(20.18 M)
(39.92 M)
(18.2 M)
(78.88 M)
(104.58 M)
(168.45 M)
(98.34 M)
(87.61 M)
Current Valuation
512.86 M
85.08 M
44 M
204.6 M
1.55 M
(86.26 M)
290.01 M
2.73 B
(27.82 M)
(38.23 M)
Price To Book
0.91
1.74
32.55
4.06
1.93
0.42
2.53
35.37
0.43
0.5
Operating Margin
N/A
-4.17
N/A
-11.31
N/A
N/A
N/A
N/A
N/A
-14.27
Retained Earnings
(261.67 M)
(384.86 M)
(63.98 M)
(308.82 M)
(239.32 M)
(310 M)
(305.63 M)
(676.42 M)
(594.47 M)
(306.31 M)
Current Asset
238.83 M
12.84 M
N/A
4.48 M
N/A
N/A
N/A
N/A
144.91 M
N/A
Beta
0.77
1.28
0.34
0.81
99.48
1.48
2.03
0.48
1.2
1.86
Number Of Employees
46
68
13
66
7
63
74
150
58
75
Shares Outstanding
36.52 M
228.31 M
25.33 M
36.18 M
1.05 M
51.75 M
57.3 M
93.61 M
61.77 M
47.74 M
Cash Flow From Operations
(58.24 M)
(28.57 M)
(13.07 M)
(47.42 M)
(14.3 M)
(55.66 M)
(83.73 M)
(145.23 M)
(78.26 M)
(81.23 M)
Total Debt
42.95 M
2.95 M
7.09 M
120.37 M
47 K
13.29 M
2.42 M
61.82 M
26.29 M
4.2 M
Return On Equity
-1.0
-0.35
-5.6
-34.39
-1.91
-0.24
-0.52
-1.83
-0.64
-0.68
Z Score
-4.41
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.42
-0.13
-1.07
-0.25
-0.19
-0.2
-0.32
-0.67
-0.34
-0.4
Number Of Shares Shorted
365.89 K
15.94 M
662.41 K
4.54 K
14.52 K
847.18 K
8.31 M
15.31 M
1.64 M
2.19 M
Book Value Per Share
1.0
0.36
0.028
-0.89
2.39
3.82
3.47
0.99
2.03
3.06
Current Liabilities
56.95 M
2.74 M
N/A
4.08 M
N/A
N/A
N/A
N/A
3.09 M
N/A
Total Asset
121.24 M
101.02 M
7.57 M
98.36 M
7.78 M
252.15 M
276.94 M
311.04 M
150.54 M
159.56 M
Debt To Equity
0.47
0.036
N/A
0.73
N/A
0.045
0.013
0.22
0.11
0.023
Short Ratio
3.51
35.21
10.99
0.86
0.16
4.16
24.76
4.12
6.61
1.76
Target Price
0.5
4.57
12.63
7.0
140.0
5.8
27.86
39.88
7.67
2.0
Shares Owned By Institutions
14.12
50.56
7.5
3.82
13.97
80.89
96.33
98.3
59.68
74.67
Market Capitalization
10.94 M
115.05 M
52.69 M
81.41 M
4.85 M
83.31 M
503.07 M
2.8 B
31.19 M
47.98 M
Price To Earning
-7.43
3.62
N/A
-1.64
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earnings To Growth
N/A
N/A
N/A
N/A
N/A
-0.31
N/A
N/A
N/A
N/A
Price To Sales
7.5
18.6
N/A
21.89
N/A
N/A
N/A
13.14
N/A
11.63
Net Income
(81.58 M)
(21.49 M)
(19.77 M)
(69.05 M)
(75.34 M)
(68.96 M)
(96.66 M)
(165.79 M)
(102.06 M)
(87.3 M)
Earnings Per Share
-1.9
-0.08
-1.34
-1.15
24.4
-1.0
-2.28
-2.36
-1.17
-1.53
Shares Owned By Insiders
7.26
0.44
17.49
70.24
29.8
2.3
3.67
1.07
0.49
13.41
Revenue
N/A
8.95 M
N/A
4.53 M
N/A
N/A
N/A
N/A
N/A
1.66 M
Working Capital
66.47 M
20.48 M
2.63 M
2.69 M
4.82 M
193.38 M
244.89 M
255.45 M
101.62 M
131.77 M
Cash And Equivalents
111.02 M
66.36 M
8.15 M
36.98 M
21.18 M
277.43 M
240.71 M
370.69 M
239.25 M
214.24 M
Cash Per Share
3.15
0.39
0.75
1.02
1.25
6.08
6.01
7.18
4.39
5.09
Gross Profit
(42.02 M)
13.97 M
N/A
(29.51 M)
N/A
N/A
N/A
(89.85 M)
N/A
(82.25 M)
Day Typical Price
0.52
0.54
2.12
2.22
4.64
1.61
8.53
28.8
0.52
0.99
Accumulation Distribution
0.25
0.19
0.0633
0.0487
0.14
0.0545
0.11
0.12
0.11
0.0784
Market Facilitation Index
0.15
0.12
0.14
0.11
0.71
0.09
0.99
3.7
0.06
0.08
Daily Balance Of Power
(0.20)
(0.83)
(0.50)
1.363636
0.1408
0.4444
0.9192
0.8784
(0.50)
(0.12)
Period Momentum Indicator
(0.03)
(0.10)
(0.07)
0.15
0.1
0.04
0.91
3.25
(0.03)
(0.01)
Rate Of Daily Change
0.95
0.83
0.97
1.07
1.02
1.03
1.12
1.12
0.94
0.99
Day Median Price
0.53
0.56
2.14
2.21
4.64
1.61
8.41
28.24
0.53
0.98
Price Action Indicator
(0.02)
(0.11)
(0.1)
0.12
0.025
0.025
0.83
3.31
(0.04)
0.015
Relative Strength Index
29.91
27.13
24.74
60.68
66.04
61.73
22.6
67.79
46.44
50.76
Coefficient Of Variation
1460.07
(753.06)
(1,198)
3456.92
910.98
5076.24
(1,149)
881.01
(1,637)
(631.92)
Mean Deviation
4.38
3.42
3.88
3.29
10.49
1.67
2.79
11.32
4.69
4.98
Jensen Alpha
0.8112
(0.95)
(0.53)
0.0605
2.27
0.0222
(0.63)
6.09
(0.62)
(1.61)
Total Risk Alpha
(0.94)
(1.57)
(1.24)
(0.65)
(1.11)
(0.35)
(0.96)
(1.98)
(1.28)
(2.67)
Sortino Ratio
0.106
N/A
N/A
0.0029
0.2232
(0.03)
N/A
1.03
N/A
N/A
Downside Variance
30.49
N/A
N/A
17.36
115.0
6.28
N/A
23.32
N/A
N/A
Standard Deviation
10.46
5.36
5.1
4.94
22.99
2.47
3.88
44.83
5.79
8.44
Kurtosis
46.01
11.87
0.875
6.01
20.48
2.58
1.7
64.62
(0.53)
13.59
Potential Upside
5.71
6.98
8.37
7.14
15.56
3.75
5.58
7.58
9.33
7.03
Treynor Ratio
(0.81)
(0.38)
(0.57)
0.2216
1.23
0.2848
(0.15)
(0.61)
(0.17)
(0.61)
Maximum Drawdown
90.18
39.6
28.1
33.83
154.25
13.98
19.19
375.97
25.5
52.02
Variance
109.38
28.75
25.98
24.45
528.73
6.08
15.03
2009.99
33.57
71.23
Market Risk Adjusted Performance
(0.80)
(0.37)
(0.56)
0.2316
1.24
0.2948
(0.14)
(0.60)
(0.16)
(0.60)
Risk Adjusted Performance
0.0618
(0.09)
(0.06)
0.0306
0.0939
0.022
(0.06)
0.0969
(0.04)
(0.11)
Skewness
6.21
(2.35)
0.2899
1.41
4.21
0.707
(0.10)
8.0
(0.14)
(3.01)
Semi Deviation
3.9
N/A
N/A
3.71
9.06
2.12
N/A
3.23
N/A
N/A
Information Ratio
0.056
(0.16)
(0.11)
0.0025
0.1041
(0.03)
(0.12)
0.1106
(0.08)
(0.17)
Value At Risk
(6.15)
(5.49)
(9.23)
(7.05)
(14.59)
(3.77)
(5.89)
(6.99)
(9.88)
(9.82)
Expected Short fall
(7.60)
N/A
N/A
(4.49)
(12.32)
(1.94)
N/A
(14.89)
N/A
N/A
Downside Deviation
5.52
N/A
N/A
4.17
10.72
2.51
N/A
4.83
N/A
N/A
Semi Variance
15.2
N/A
N/A
13.74
82.08
4.48
N/A
10.45
N/A
N/A

Frequency Therapeutics Competition Performance Charts

Five steps to successful analysis of Frequency Therapeutics Competition

Frequency Therapeutics' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Frequency Therapeutics in relation to its competition. Frequency Therapeutics' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Frequency Therapeutics in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Frequency Therapeutics' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Frequency Therapeutics, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Frequency Therapeutics position

In addition to having Frequency Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Robots And Drones Thematic Idea Now

Robots And Drones
Robots And Drones Theme
Large technology companies that are involved in development and manufacturing of drones, robots, or robotic equipment across mechanical engineering, electrical engineering, mathematics and computer science fields. Drones and robotics are projected to significantly grow in demand in the next 5 years. The Robots And Drones theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Robots And Drones Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Frequency Stock

If you are still planning to invest in Frequency Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Frequency Therapeutics' history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY